Trial
NCT03879811
Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Bristol-Myers Squibb
Condition
Colorectal Cancer
Intervention
TMZ
Why stopped
No accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-15